Spok Holdings, Inc. SPOK R2K

Healthcare · Health Information Services · United States

https://www.spok.com

Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance. The company delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager. It offers subscriptions to one-way or two-way messaging services, as well as alphanumeric pagers that are configurable to support unencrypted or encrypted operation; and ancillary services, such as voicemail, and equipment loss or maintenance protection services, as well as sells devices to resellers who lease or resell them to their subscribers. The company provides Spok Care Connect suite products for contact centers, clinical alerting and notification, mobile communications and messaging, and public safety notifications. In addition, it provides professional, software license updates, and product support services, as well as sells third-party equipment. It serves businesses, professionals, management personnel, medical personnel, field sales personnel and service forces, members of the construction industry and construction trades, real estate brokers and developers, sales and services organizations, specialty trade organizations, manufacturing organizations, and government agencies. The company was formerly known as USA Mobility, Inc. and changed its name to Spok Holdings, Inc. in July 2014. Spok Holdings, Inc. was founded in 1986 and is headquartered in Plano, Texas.

Market & Price

Market Cap

$221.19M

Current Price

$10.59

High / Low (52W)

$17.03 / $10.24

Beta

0.43

Valuation

Stock P/E

17.95

Industry PE

23.65

Forward P/E

12.61

PEG Ratio

Book Value

$6.75

Price to Book

1.57

P/S

1.62

EV/EBITDA

10.30

Dividend Yield

11.80%

Profitability & Returns

ROCE

12.85%

ROE

8.66%

ROA

5.29%

Profit Margin

9.27%

Op Margin

8.33%

EPS (Latest Qtr)

$0.09

EPS (TTM)

$0.59

Balance Sheet & Liquidity

Debt/Equity

4.41

Quick Ratio

0.85

Current Ratio

1.09

Debt

$6.21M

Total Assets

$206.11M

Current Assets

$57.88M

Working Capital

$8.78M

Ownership

Promoter Holding

2.34%

Chg in Prom Hold

FII / Inst Holding

56.30%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$210.32M

Total Revenue (TTM)

$136.64M

EBITDA

$20.42M

Free Cash Flow

$19.75M

Operating Cash Flow

$29.14M

Shares Outstanding

20.89M

Gross Margin

59.89%

Payout Ratio

211.86%

Growth (CAGR)

Revenue 5Y

1.27%

Profit 5Y

-10.10%

Revenue (YoY)

-8.50%

Earnings (YoY)

-64.00%

PROS

Attractive dividend yield of 11.80%.
Generates positive free cash flow.

CONS

Earnings shrank at -10.1% CAGR over 5 years.
Trading 37.8% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	SPOK Spok Holdings, Inc. R2K	10.59	17.95	$221.19M	11.80%	12.85%	8.66%	1.27%	-10.10%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	41.44M	42.33M	43.64M	43.77M	43.11M	40.63M	42.48M	43.26M	41.76M	39.52M	39.45M	39.55M	37.27M	35.74M	37.69M	37.48M	36.04M	35.72M	35.85M	33.83M	33.71M	33.74M	33.18M	36.46M	35.43M	34.91M	33.98M	-	36.29M	35.69M	33.87M	33.86M	33.23M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.28M	7.33M	7.36M	7.88M	7.73M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29.01M	28.36M	26.51M	25.98M	25.50M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22.93M	22.94M	21.98M	21.83M	22.73M
Operating Income	5.62M	6.66M	6.55M	5.80M	5.62M	6.03M	4.70M	1.38M	2.41M	3.33M	3.59M	584.00K	-2.35M	-1.56M	149.00K	1.11M	-1.99M	-2.69M	-12.24M	-4.11M	3.16M	2.73M	-24.45M	-1.74M	-1.61M	-3.56M	-8.67M	2.41M	3.54M	4.72M	6.21M	6.21M	4.89M	4.47M	-	6.08M	5.41M	4.53M	4.15M	2.77M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.93M	6.27M	5.39M	5.08M	3.76M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.26M	6.38M	4.58M	4.22M	2.62M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.06M	1.83M	1.38M	1.29M	636.00K
Net Income	3.38M	4.22M	68.73M	3.44M	3.45M	4.06M	3.03M	854.00K	1.50M	3.73M	21.38M	345.00K	-1.17M	-840.00K	189.00K	742.00K	-670.00K	-1.33M	-9.51M	-4.54M	3.76M	3.17M	-46.61M	-2.30M	-719.00K	-7.21M	-7.21M	1.92M	2.92M	3.12M	4.73M	4.45M	4.24M	3.42M	-	5.20M	4.55M	3.20M	2.93M	1.99M
Diluted EPS	0.16	0.20	3.53	0.17	0.17	0.20	-	-	0.07	-	-	-	-0.05	-	-	-	-	-0.07	-	-0.24	0.20	0.16	-2.44	-0.12	-0.04	-0.13	-0.37	0.10	0.15	0.15	0.23	0.22	0.21	0.17	-	0.25	0.22	0.15	0.14	0.09
R&D Expense	-	-	-	2.91M	3.21M	3.65M	-	4.11M	4.66M	5.00M	-	5.74M	6.18M	5.93M	-	6.17M	6.81M	7.44M	-	5.45M	2.75M	3.46M	-	4.44M	4.16M	4.06M	6.50M	2.62M	2.22M	2.49M	2.85M	2.56M	2.95M	3.18M	2.83M	3.09M	3.02M	2.99M	-	3.46M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	179.56M	171.18M	169.47M	160.29M	148.18M	-	134.53M	139.03M	137.65M	139.71M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	28.27M	27.09M	28.71M	29.79M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	106.27M	111.93M	108.95M	109.92M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	98.70M	90.13M	88.88M	89.75M
Operating Income	57.41M	57.18M	51.83M	45.73M	45.49M	28.15M	25.10M	22.15M	10.71M	-3.17M	-15.81M	-22.66M	-	7.57M	21.80M	20.07M	20.17M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	11.14M	26.30M	24.22M	23.60M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	997.00K	22.32M	20.03M	21.44M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-20.86M	6.66M	5.07M	5.56M
Net Income	67.56M	77.90M	83.79M	26.98M	27.53M	20.75M	80.25M	13.98M	-15.31M	-1.48M	-10.77M	-44.23M	-	21.86M	15.67M	14.96M	15.88M
Diluted EPS	2.90	3.45	3.72	1.20	1.25	0.94	3.98	-	-	-	-0.56	-2.32	-	1.09	0.77	0.73	0.75
R&D Expense	-	-	-	8.90M	8.70M	9.50M	10.28M	13.47M	18.70M	24.46M	27.54M	15.74M	17.51M	13.62M	10.68M	11.69M	12.22M

Compounded Sales Growth

5 Years:	1.27%
1 Year:	-8.50%

Compounded Profit Growth

5 Years:	-10.10%
1 Year:	-64.00%

Stock Price Performance

1 Year:	-27.98%
6 Months:	-14.51%
3 Months:	-7.75%
1 Month:	-1.35%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	230.66M	354.42M	322.63M	326.90M	337.89M	386.43M	388.09M	348.00M	327.71M	319.87M	277.29M	-	244.48M	227.68M	217.10M	206.11M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70.05M	63.89M	61.30M	57.88M
Cash & Equivalents	75.03M	109.59M	129.22M	53.66M	61.05M	89.08M	107.87M	109.33M	121.83M	103.18M	83.34M	47.36M	48.73M	-	35.75M	31.99M	29.14M	25.28M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	26.86M	23.31M	21.95M	22.64M
Total Liabilities	-	-	46.27M	97.62M	71.21M	56.95M	58.83M	56.87M	66.00M	57.48M	53.16M	69.78M	76.68M	-	73.38M	63.91M	62.36M	59.73M
Current Liabilities	-	-	34.48M	56.57M	60.73M	46.83M	49.76M	47.16M	56.33M	48.34M	44.95M	51.18M	57.44M	-	54.43M	48.01M	48.77M	49.11M
Long Term Debt	-	-	0	28.25M	0	0	0	-	-	-	-	-	-	-	-	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.70M	11.09M	8.77M	6.94M
Total Equity	140.74M	158.80M	184.39M	247.59M	251.42M	269.95M	279.06M	329.56M	322.09M	290.53M	274.55M	250.09M	199.63M	-	171.10M	163.77M	154.75M	146.38M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20.08M	19.99M	20.28M	20.61M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	101.86M	79.42M	82.44M	72.88M	50.46M	41.56M	41.84M	37.55M	15.52M	10.31M	11.69M	26.16M	-	6.46M	26.18M	28.92M	28.95M
Investing Cash Flow	-17.06M	-6.66M	-134.65M	-12.66M	-10.12M	-7.61M	-5.57M	-8.23M	-9.17M	-5.83M	-30.22M	-14.57M	-	11.26M	-3.42M	-3.21M	-3.05M
Financing Cash Flow	-50.24M	-53.13M	-23.35M	-52.83M	-12.31M	-15.15M	-32.81M	-16.72M	-25.00M	-24.28M	-17.15M	-10.37M	-	-26.22M	-26.68M	-28.54M	-29.79M
Capital Expenditure	-17.23M	-8.74M	-7.95M	-9.99M	-10.41M	-7.61M	-5.57M	-6.25M	-9.21M	-5.92M	-4.84M	-3.46M	-	-3.78M	-3.42M	-3.21M	-3.75M
Free Cash Flow	84.63M	70.68M	74.48M	62.89M	40.05M	33.95M	36.27M	31.30M	6.30M	4.40M	6.86M	22.71M	-	2.68M	22.77M	25.71M	25.20M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-8.51M	-3.91M	-2.82M	-3.89M
Share Buybacks	4.74M	8.89M	0	8.06M	0	4.33M	15.01M	6.49M	10.02M	13.48M	6.58M	0	0	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	79.0%	80.5%	79.1%	78.7%
Operating Margin %	-	-	-	-	-	-	-	12.3%	6.3%	-1.9%	-9.9%	-15.3%	-	5.6%	15.7%	14.6%	14.4%
Net Margin %	-	-	-	-	-	-	-	7.8%	-8.9%	-0.9%	-6.7%	-29.8%	-	16.2%	11.3%	10.9%	11.4%
ROE %	42.5%	42.2%	33.8%	10.7%	10.2%	7.4%	24.3%	4.3%	-5.3%	-0.5%	-4.3%	-22.2%	-	12.8%	9.6%	9.7%	10.8%
ROCE %	-	29.1%	17.4%	17.5%	16.2%	9.8%	7.4%	6.7%	3.6%	-1.1%	-5.9%	-10.3%	-	4.0%	12.1%	11.9%	12.8%

Shareholding Pattern

Insiders

2.34%

Institutions

56.30%

Public Float

57.65%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	8.03%	1.68M	$17.75M
2	Renaissance Technologies, LLC	6.04%	1.26M	$13.36M
3	Vanguard Capital Management LLC	4.12%	859.53K	$9.10M
4	Dimensional Fund Advisors LP	3.43%	715.87K	$7.58M
5	Geode Capital Management, LLC	2.61%	545.72K	$5.78M
6	State Street Corporation	2.21%	461.79K	$4.89M
7	HighTower Advisors, LLC	1.83%	381.81K	$4.04M
8	Vanguard Portfolio Management LLC	1.27%	265.03K	$2.81M
9	Goldman Sachs Group Inc	1.05%	219.58K	$2.33M
10	Bank Of New York Mellon Corporation	1.04%	217.80K	$2.31M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SPOK

No recent headlines available.

SPOK · Healthcare